📰 Core Opinc News
Core Opinc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Core Opinc. Real-time updates on events, politics, business and more.
July 10, 2023
(RTTNews) - Novartis (NVS) said the U.S. District Court for the District of Delaware ruled the Entresto (sacubitril / valsartan) combination pate...
July 7, 2023
Ad hoc announcement pursuant to Art. 53 LR U.S. District Court for the District of Delaware ruled the Entresto (sacubitril / valsartan) ‘combination patent’ to be invalid Novartis will appeal to the U.S. Court of Appeals for the Federal Circuit to reverse the District Court’s rulingNo generic Entresto product has received FDA approval as of todayPending a final appeal decision and other ongoing litigation involving multiple patents, any launch once generics receive FDA appro...
July 7, 2023
Ad hoc announcement pursuant to Art. 53 LR U.S. District Court for the District of Delaware ruled the Entresto ‘combination patent’ to be invalid Novartis will appeal to the U.S....
April 25, 2023
Ad hoc announcement pursuant to Art. 53 LR Q1 sales grew +8% (cc1, +3% USD) and core operating income grew +15% (cc, +8% USD) Innovative Medicines (IM) sales grew +7% (cc, +3% USD) and core operating